Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.03
-0.50 (-2.44%)
At close: Jun 12, 2026, 4:00 PM EDT
20.09
+0.06 (0.30%)
After-hours: Jun 12, 2026, 4:10 PM EDT
Amphastar Pharmaceuticals Revenue
Amphastar Pharmaceuticals had revenue of $171.17M in the quarter ending March 31, 2026, with 0.38% growth. This brings the company's revenue in the last twelve months to $720.53M, down -1.39% year-over-year. In the year 2025, Amphastar Pharmaceuticals had annual revenue of $719.89M, down -1.65%.
Revenue (ttm)
$720.53M
Revenue Growth
-1.39%
P/S Ratio
1.23
Revenue / Employee
$364,641
Employees
1,976
Market Cap
885.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 719.89M | -12.08M | -1.65% |
| Dec 31, 2024 | 731.97M | 87.57M | 13.59% |
| Dec 31, 2023 | 644.40M | 145.41M | 29.14% |
| Dec 31, 2022 | 498.99M | 61.22M | 13.98% |
| Dec 31, 2021 | 437.77M | 87.92M | 25.13% |
| Dec 31, 2020 | 349.85M | 27.49M | 8.53% |
| Dec 31, 2019 | 322.36M | 27.69M | 9.40% |
| Dec 31, 2018 | 294.67M | 54.49M | 22.69% |
| Dec 31, 2017 | 240.18M | -14.99M | -5.87% |
| Dec 31, 2016 | 255.17M | 3.65M | 1.45% |
| Dec 31, 2015 | 251.52M | 41.06M | 19.51% |
| Dec 31, 2014 | 210.46M | -19.22M | -8.37% |
| Dec 31, 2013 | 229.68M | 25.36M | 12.41% |
| Dec 31, 2012 | 204.32M | 85.97M | 72.63% |
| Dec 31, 2011 | 118.36M | -12.38M | -9.47% |
| Dec 31, 2010 | 130.74M | 46.46M | 55.13% |
| Dec 31, 2005 | 84.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Phibro Animal Health | 1.50B |
| Evotec SE | 859.03M |
| Collegium Pharmaceutical | 796.33M |
| Pacira BioSciences | 734.86M |
| Alvotech | 562.04M |
| Esperion Therapeutics | 418.24M |
| Ironwood Pharmaceuticals | 361.51M |
| Xeris Biopharma Holdings | 314.85M |
AMPH News
- 4 days ago - Amphastar Pharmaceuticals Transcript: 16th Annual East Coast IDEAS Conference - Transcripts
- 6 days ago - Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 11 days ago - Amphastar Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Amphastar Pharmaceuticals Slides: FY 2026 - Filings
- 11 days ago - Amphastar price target lowered to $20 from $23 at Barclays - TheFly
- 13 days ago - Amphastar Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 18 days ago - Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference - Accesswire
- 4 weeks ago - Amphastar downgraded to Equal Weight from Overweight at Wells Fargo - TheFly